Re-Use of Established Drugs for Anti-Metastatic Indications

Most patients that die from cancer do not die due to the primary tumor but due to the development of metastases. However, there is currently still no drug on the market that specifically addresses and inhibits metastasis formation. This lack was, in the past, largely due to the lack of appropriate s...

Full description

Bibliographic Details
Main Authors: Frank Entschladen, Dane A. Thyssen, David W. Drell
Format: Article
Language:English
Published: MDPI AG 2016-01-01
Series:Cells
Subjects:
Online Access:http://www.mdpi.com/2073-4409/5/1/2

Similar Items